Investing

American flags in front of Goldman Sachs Group Inc. headquarters in New York, on Friday, March 5, 2021.
Michael Nagle | Bloomberg | Getty Images

Goldman Sachs said that only vaccinated people can enter its buildings starting next month.

The leading global investment bank said that the new policy starts Sept. 7 and applies to everybody, including employees and clients, according to a memo sent to U.S. workers on Tuesday.  Those who aren’t fully vaccinated by then will have to work from home, according to a person with direct knowledge of the memo.

Goldman Sachs is the latest bank to require employees be vaccinated to return to offices, following similar edicts from Morgan Stanley and Citigroup. The move comes the day after the U.S. Food and Drug Administration gave full approval to the Pfizer-BioNTech vaccine, clearing the way for more corporations to mandate their employees be vaccinated.

The bank is also implementing a mandatory weekly testing program for vaccinated workers on Sept. 7, according to the person, who declined to be identified when speaking about personnel matters. The memo was reported earlier by the New York Times.

Goldman will also require mask-wearing in all common areas including lobbies, hallways, gyms and cafeterias, except when seated and eating or drinking. In cities including San Francisco and Washington, masks will be required at all times, except when eating or drinking, because of local health guidance.

This story is developing. Please check back for updates.

Become a smarter investor with CNBC Pro
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. 
Sign up to start a free trial today.

Articles You May Like

Finland seizes Russian shadow fleet oil tanker after cable-cutting incident
November home sales surged more than expected, boosted by lower mortgage rates
San Francisco loses second triple-A rating
Nvidia sees ‘remarkable’ influx of retail investor dollars as traders flock to AI darling
Matt Gaetz accused of paying for sex and using drugs by US congressional panel